Organ preservation with targeted rapamycin nanoparticles: a pre-treatment strategy preventing chronic rejection in vivo

Peng Zhu,Carl Atkinson,Suraj Dixit,Qi Cheng,Danh Tran,Kunal Patel,Yu-Lin Jiang,Scott Esckilsen,Kayla Miller,Grace Bazzle,Patterson Allen,Alfred Moore,Ann-Marie Broome,Satish N. Nadig,Satish N. Nadig
DOI: https://doi.org/10.1039/c8ra01555d
IF: 4.036
2018-01-01
RSC Advances
Abstract:(a) Rapamycin nanotherapeutic pre-treatment improves tracheal allograft outcome after transplantation. (b) Nanotherapy reduces aortic allograft vasculopathy. (c) Dose dependency of the nanotherapy in aortic interposition allografts.
chemistry, multidisciplinary
What problem does this paper attempt to address?